Greco, Lucia Catherine http://orcid.org/0000-0003-3659-4034
Lizio, Andrea http://orcid.org/0000-0002-8875-9665
Casiraghi, Jacopo
Sansone, Valeria Ada http://orcid.org/0000-0002-1354-3800
Tremolizzo, Lucio http://orcid.org/0000-0003-0473-6560
Riva, Nilo http://orcid.org/0000-0002-0513-9517
Solca, Federica http://orcid.org/0000-0002-3274-3963
Torre, Silvia
Ticozzi, Nicola http://orcid.org/0000-0001-5963-7426
Filippi, Massimo http://orcid.org/0000-0002-5485-0479
Silani, Vincenzo http://orcid.org/0000-0002-7698-3854
Poletti, Barbara http://orcid.org/0000-0003-4398-2051
Lunetta, Christian http://orcid.org/0000-0002-4788-1875
Article History
Received: 3 May 2021
Revised: 5 August 2021
Accepted: 6 August 2021
First Online: 19 August 2021
Declarations
:
: CL received compensation for occasional scientific consulting from Neuraltus, Cytokinetics, Mitsubishi Tanabe Pharma Europe and Italfarmaco and has received funds from ARISLA and Italian Ministry of Health, AL received compensation for occasional scientific consulting from Italfarmaco, VAS participates in Advisory Boards or Teaching activities for Biogen, Roche, Avexis, PTC, Santhera, and Sarepta, Dyne. Other authors declared no disclosures.
: The study design was approved by the institutional ethical committees of Milano Area 3 and all the subjects involved signed the informed consent in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
: All the subjects involved in the study participated willingly.
: All the subjects involved signed the informed consent for publication data.